当前位置:首页 - 行情中心 - 三诺生物(300298) - 财务分析

三诺生物

(300298)

  

流通市值:86.33亿  总市值:107.18亿
流通股本:4.51亿   总股本:5.60亿

三诺生物(300298)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.53亿元,每股收益0.38元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益367460.97万元,未分配利润123625.40万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产624844.76万元,负债257383.79万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入3,453,271,477.262,263,667,609.811,041,603,772.084,443,123,570.61
营业总成本3,338,133,962.972,116,582,036988,932,886.514,041,229,082.16
其他经营收益
营业利润176,616,106.29192,413,943.3793,087,025.77398,977,729.7
利润总额190,767,223.84206,875,786.593,047,997.03395,261,182.41
净利润152,743,949.16182,071,127.8481,361,076.86345,854,598.97
每股收益
其他综合收益-4,351,539.613,304,077.19-7,243,403.2724,447,503.61
综合收益总额148,392,409.56195,375,205.0374,117,673.59370,302,102.58
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,582,645,054.192,357,921,451.122,325,701,337.462,381,879,275.58
非流动资产:
非流动资产合计3,665,802,537.873,667,414,832.733,667,951,241.423,715,685,676.8
资产总计6,248,447,592.066,025,336,283.855,993,652,578.886,097,564,952.38
流动负债:
流动负债合计1,812,316,552.131,548,464,272.331,436,504,702.251,693,710,727.36
非流动负债:
非流动负债合计761,521,326.37710,396,955.25707,087,470.57634,238,042.5
负债合计2,573,837,878.52,258,861,227.582,143,592,172.822,327,948,769.86
所有者权益(或股东权益):
归属于母公司股东权益合计3,319,385,541.983,344,792,032.273,430,657,013.793,357,739,858.8
股东权益合计3,674,609,713.563,766,475,056.273,850,060,406.063,769,616,182.52
负债和股东权益合计6,248,447,592.066,025,336,283.855,993,652,578.886,097,564,952.38
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计3,718,770,391.372,378,494,643.811,221,076,384.984,493,985,390.69
经营活动现金流出小计3,181,541,417.712,105,129,812.181,023,997,765.13,862,696,491.52
经营活动产生的现金流量净额537,228,973.66273,364,831.63197,078,619.88631,288,899.17
投资活动产生的现金流量:
投资活动现金流入小计964,855,988.98570,807,235.26314,164,040.59491,652,546.59
投资活动现金流出小计1,238,574,006.53621,481,224.74269,346,029.2666,668,722.05
投资活动产生的现金流量净额-273,718,017.55-50,673,989.4844,818,011.39-175,016,175.46
筹资活动产生的现金流量:
筹资活动现金流入小计288,150,542.75149,435,572.6595,764,138.73231,514,750.02
筹资活动现金流出小计558,186,348.08463,916,611.43250,286,363.4615,788,268.02
筹资活动产生的现金流量净额-270,035,805.33-314,481,038.78-154,522,224.67-384,273,518
汇率变动对现金及现金等价物的影响-1,918,721.911,870,204.87577,999.3-9,210,729.26
现金及现金等价物净增加额-8,443,571.13-89,919,991.7687,952,405.962,788,476.45
期末现金及现金等价物余额834,011,321.09752,534,900.46929,415,113.25842,454,892.22
补充资料:
现金及现金等价物的净增加额--89,919,991.76-62,788,476.45
最新报告期:2025-10-23
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国金证券何冠洲0.530.921.142025-10-23
中信建投王在存,贺菊颖0.710.921.122025-10-14
华创证券郑辰,李婵娟0.770.931.122025-10-09
中信证券宋硕,陈竹,沈睦钧0.750.921.102025-09-12
华安证券李婵,谭国超0.760.961.192025-09-10
TOP↑